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cancer
Abstract
Introduction: The frequency of detection of peripheral pulmonary lesion (PPL) in suspected early lung cancer has been increasing, 
and whether preoperative pathological diagnosis (PPD) for small PPLs should always be established before their surgical resection 
can become a worrisome problem for physicians. The aim of the study was to clarify the impact of obtaining PPD on surgical and 
postoperative outcomes of lung resection for early stage lung cancer.
Material and methods: This was a retrospective review of cases that underwent surgical resection for known or suspected pri-
mary lung cancer presenting pathological stage 0 or I, enrolled from June 2006 to May 2016. The patients divided into two groups 
according to PPD group (n = 57) and non-PPD group (n = 157) were compared. The procedure, node dissection, operation time, 
amount of bleeding, postoperative complications, postoperative length of stay, and postoperative recurrences were analyzed.
Results: Among the 214 patients, no significant differences in operation time (248.5 ± 88.6 versus 257.6 ± 89.0, min, mean 
± SD, p = 0.328), amount of bleeding (195.3 ± 176.5 vs 188.1 ± 236.1, ml, p = 0.460), postoperative complication (5.2% vs 
4.5%, p = 0.728), postoperative length of stay (10.6 ± 6.3 vs 10.4 ± 5.3, days, p = 0.827), or postoperative recurrences (21.0% 
vs 17.2%, p = 0.550) were seen between PPD and non-PPD groups.
Conclusion: Therefore, PPD had less impact on surgical and postoperative outcomes of pathological stage 0 or I lung cancer; 
direct surgical resection without non-surgical biopsy would be acceptable with careful selection of cases.
Key words: lung cancer, transbronchial biopsy, CT-guided needle biopsy, peripheral pulmonary lesion, video-assisted thoracic 
surgery
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Introduction
Lung cancer is one of the most important cau-
ses of cancer-related deaths over the world [1–3]. 
Since the widespread using of low-dose computed 
tomography (CT) screening promised to reduce 
lung cancer mortality, the detection and diagno-
sis rate of peripheral pulmonary lesions (PPLs) 
has increased [4]. PPLs have a high incidence 
of lung cancer at an early stage [4]. To improve 
the survival outcomes of lung cancer, prompt 
surgical resection that is a preferred treatment 
for localized lung cancer is important. However, 
it involves the risk of unnecessary resections 
of benign lesions when preoperative definitive 
diagnosis is not established. The unnecessary 
surgical resection rates for benign diseases are 
reported to be from 9% to 40% [5, 6]. Therefore, 
preoperative pathological confirmations of PPLs 
by non-surgical biopsy, such as CT-guided needle 
biopsy and bronchoscopy, are important to avoid 
unnecessary surgical resections. In the recent 
study, the preoperative pathological diagnosis 
(PPD) by non-surgical biopsy have resulted in 
a low rate of benign resection [7].
Ideally, PPD for PPLs, which can represent 
benign diseases as well as localized lung cancer, 
should always be established by non-surgical mo-
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dalities before their surgical resections. Although 
ideal, in the clinical settings surgical resections 
without PPD are often performed considering the 
high death rate of unresected lung cancer; besides 
there is a question of uncertainty, difficulty and 
risk of complications of non-surgical biopsy [8]. 
Furthermore, a recent study reported that follo-
wing the recommendation of CT screening pro-
tocol has decreased the rate of benign resection 
by less than 2% and has not missed lung cancer 
cases [5]. Therefore, there is a controversy on the 
real benefit of non-surgical biopsy for PPLs in 
suspected lung cancer on a routine basis.
The aim of the study was to clarify the impact 
of obtaining PPD on surgical and postoperative 
outcomes of lung resection of early stage lung 
cancer, which would provide both patients and 
doctors with useful information about whether 




Consecutive patients who underwent surgi-
cal resection for known or suspected first primary 
lung cancer presenting pathological stage 0 or 
I at Japanese Red Cross Medical Center, between 
June 2006 and May 2016 were enrolled. Patients 
with multiple pulmonary lesions, those with hi-
story of cancer treated within past 5 years, those 
who were postoperatively diagnosed as patho-
logical stage II–IV lung cancer, and those finally 
diagnosed with benign disease were excluded 
from the study. High-resolution computed to-
mography (HRCT) or 18-fluoro-deoxyglucose 
positron emission tomography (FDG-PET) were 
undertaken before surgery for all patients staged 
according to the TNM Classification of Malignant 
Tumors, seventh edition. CT-guided needle biopsy 
or bronchoscopy were performed for PPD of PPLs 
according to the physician’s discretion. 
All operations were video-assisted thoracic 
surgery (VATS). Sublobar resection (segmen-
tectomy or wedge resection) was allowed in 
cases assessed intraoperatively as non-invasive 
adenocarcinoma and cases with no lymph node 
metastasis regarded as unsuitable for lobecto-
my considering factors such as age, pulmonary 
function, and general condition. Data on patient 
characteristics, chest CT and FDG-PET findin-
gs of PPLs, results of preoperative diagnostic 
examination performed in cases (diagnosed or 
undiagnosed), and patients’ outcomes were re-
trospectively analyzed. This retrospective study 
was approved by the Institutional Review Board 
of Japanese Red Cross Medical Center (No. 912, 
UMIN000033593). 
Assessment
To evaluate the impact of obtaining PPD on 
surgery, postoperative records in the patients with 
PPD (PPD group) and in the patients without PPD 
(non-PPD group) were compared. The surgical 
records were analyzed as follows: procedure (lo-
bectomy or sublobar resection), node dissection 
(no lymphadenectomy, hilar lymphadenectomy, 
hilar and mediastinal lymphadenectomy), ope-
ration time, amount of bleeding, postoperative 
complications (≥ grade 3), postoperative length of 
stay, and postoperative recurrences. The Fischer 
exact test for categorical data and Mann-Whitney 
U test for numeric data were used to evaluate the 
significance of difference in surgical and preope-
rative records observed in the PPD and non-PPD 
groups. Descriptive statistics presented in the stu-
dy are mean ± standard deviation, frequency, and 
percentage. All reported p values were two-sided, 
and a p value < 0.05 was considered statistically 
significant. All statistical analyses were performed 
using EZR (Saitama Medical Center, Jichi Medical 
University, Saitama Japan), which is a graphical 
user interface for R (The R Foundation for Stati-
stical Computing, Vienna, Austria) [9].
Results
There were 214 patients who underwent 
surgical resection for known or suspected lung 
cancer presenting pathological stage 0 or I during 
the study period; 57 patients with PPD and 
157 patients without PPD. All Stage 0 (TisN0M0) 
cases presented with a pure ground glass nodu-
le (GGN). 59 subjects (23 patients in the PPD 
group and 36 patients in the non-PPD group) 
underwent PET/CT in the study. Intraoperative 
diagnosis was performed in all non-PPD patients. 
The study population had a mean age of 66.9 
± 9.8 years (mean ± SD) and mostly consisted 
of male patients. The mean lesion size was 
21.7 ± 9.2 mm (mean ± SD). A summary of pa-
tient characteristics is shown in Table 1. Of the 
214 patients, examinations for PPD were perfor-
med in 116 subjects (111 patients by bronchosco-
py and five patients by CT-guided needle biopsy), 
and 57 individuals were successfully diagnosed 
(52 patients by bronchoscopy and five persons by 
CT-guided needle biopsy) (Table 2). With respect 
to complications, no severe complications were 
observed in the present study. 
Takehiro Izumo et al., Preoperative confirmation of lung cancer
205www.journals.viamedica.pl
Table 1. Baseline characteristics of 214 lung cancer patients with and without preoperative tissue diagnosis
Variables All patients
 (n = 214)
PPD group




Age (years) 66.9 ± 9.8 67.0 ± 9.2 66.5 ± 10.0 0.79
Gender, no. (%) Male 140 (65.4) 41 (71.9) 99 (63.1) 0.26
Female 74 (34.6) 16 (28.1) 58 (36.9)
Smoking history Yes 141 (65.9) 38 (66.7) 103 (65.6) 1.0
No 73 (34.1) 19 (33.3) 54 (34.4)
Lesion size, mm 21.7 ± 9.2 25.2 ± 8.9 20.4 ± 9.0 0.01
Pathological stage 0 12 (5.6) 2 (3.5) 10 (6.4) 0.10
  Ia 122 (57.0) 27 (47.4) 95 (60.5)
  Ib 80 (37.4) 28 (49.1) 52 (33.1)
Histologic subtype Adenocarcinoma 153 (71.5) 41 (71.9) 112 (71.3) 0.49
Squamous cell carcinoma 45 (21.0) 10 (17.5) 35 (22.3)
Others 16 (7.5) 6 (10.6) 10 (6.4)
Variables are presented as the mean ± SD or n (%). P value is compared between PPD group and Non-PPD group 
Table 3. Comparison of surgical and postoperative outcomes between patients with PPD and those without PPD
Variables PPD group  
(n = 57)
Non-PPD group
 (n = 157)
P value
Procedure Lobectomy 52 (91.2%) 121 (77.1%) 0.02 
Sublobar resection 5 (8.8%) 36 (22.9%)
Node dissection ND0/ND1/ND2 1 (1.8%) / 2 (3.6%) / 54 (94.6%) 13 (8.2%) / 15 (9.6%) / 129 (82.2%) 0.07 
Operation time, min 248.5 ± 88.6 257.6 ± 89.0 0.33 
Amount of bleeding, ml 195.3 ± 176.5 188.1 ± 236.1 0.46 
Postoperative complication  
(≥ grade 3)
3 (5.2%) 7 (4.5%) 0.73
Postoperative length of stay, 
days
10.6 ± 6.3 10.4 ± 5.3 0.83 
Postoperative recurrences 12 (21.0%) 27 (17.2%) 0.55 
Variables are presented as the mean ± SD or n (%)
ND0 — no lymphadenectomy; ND1 — hilar lymphadenectomy; ND2 — hilar and mediastinal lymphadenectomy; PPD — preoperative pathological diagnosis
Table 2. Preoperative diagnostic modality for lesions suspected lung cancer
Procedure No. of examination No. of cases obtained PPD Percentage (%)
Bronchoscopy 111 52 46.8
CT-guided biopsy 5 5 100
CT — computed tomography; PPD — preoperative pathological diagnosis
Among the 214 patients, no significant dif-
ferences in operation time, amount of bleeding, 
postoperative complication, postoperative length 
of stay, or postoperative recurrences were seen 
between the PPD and non-PPD groups (P = 0.33, 
P = 0.46, P = 0.73, P = 0.83, and P = 0.55, re-
spectively), but the rate of lobectomy was signi-
ficantly higher in the PPD group (91.2%) than in 
the non-PPD group (77,1% P = 0.02) (Table 3). 
In the PPD group, 8 patients had local recurren-
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ce and 4 patients had distant recurrence. In the 
non-PPD group, 18 subjects had local recurrence 
and 9 patients had distant recurrence. During 
this present study period, 58 patients underwent 
surgical resection for stage II–IV (30 patients for 
stage II, 27 patients for stage III and 1 person for 
stage IV) in the non-PPD way.
Discussion
To our knowledge, this is the first report on 
the impact of preoperative pathological confir-
mation on surgical and postoperative outcomes 
of lung resection of early stage lung cancer. The 
frequency of detection of PPL in suspected early 
lung cancer has been increasing, and whether 
PPD for small PPLs should always be established 
before their surgical resection can become a wor-
risome problem for physicians. Previous studies 
have reported the high resection rates (21–34%) 
of benign lesions when preoperative pathological 
malignancy was not confirmed [5, 10]. In the cli-
nical situation, diagnosis of small benign lesions 
at peripheral pulmonary lesions are sometimes 
very difficult. However, in the present study, no 
significant differences in operation time, amount 
of bleeding, postoperative complication, postope-
rative length of stay, or postoperative recurrences 
were seen between the PPD and non-PPD groups. 
This result suggests that obtaining PPD has less 
impact on surgical and postoperative outcomes 
of pathological stage 0 or I  lung cancer except 
for decreasing benign resections. In the current 
study, 27 patients who underwent surgical resec-
tion for suspected lung cancer in the non-PPD 
group had benign lesions. In clinical practice, it 
is very difficult to diagnose “benign” with small 
specimens such as bronchoscopy or CT-guided 
needle biopsy. The cause is that only a part of 
the lesion can be sampled by those procedures. 
For these reasons, the cases finally diagnosed as 
malignant were analyzed in the current study.
When there is a  suspicion that the PPL is 
malignant, either CT-guided needle biopsy or 
bronchoscopy is often performed as non-surgical 
biopsy for PPD. The diagnostic yield of CT-guided 
needle biopsy for PPLs has been reported to be 
more than 90% [11]. However, the procedure is 
often complicated by pneumothorax (29.8%) and 
occasionally more serious complications such as 
tension pneumothorax (0.10%), tumor seeding 
(0.06%), or air embolism (0.06%) [12]. In con-
trast, bronchoscopy is a safe diagnostic method 
for peripheral pulmonary lesions. Pneumothorax 
reported as the most frequent complication asso-
ciated with bronchoscopy occurs with an inciden-
ce of around 1.0% [13]. Moreover, the diagnostic 
value of bronchoscopy has recently improved as 
a consequence of using new guiding techniques 
such as endobronchial ultrasound (R-EBUS), 
guide sheath, virtual bronchoscopy, and virtual 
fluoroscopy, so that bronchoscopy seems to be 
a feasible diagnostic modality [14–16]. However, 
previous studies have reported the decreasing dia-
gnostic yield of the bronchoscopy for the lesions 
measuring less than 20mm, those with negative 
bronchus sign on CT and those with GGNs [17].
Unfortunately, clinical stage 0 or I lung can-
cer often includes those kinds of lesions. There-
fore, physicians often puzzle over the problem 
which preoperative diagnostic modality would 
be the most suitable for lesions in suspected pa-
thological stage 0 or I lung cancer. On the other 
hand, surgical biopsy is a well-established and 
precise diagnostic modality for diagnosing PPLs. 
Importantly, the operation can consecutively be 
extended to include curative resection followed 
by surgical biopsy and confirmation of malignan-
cy of lesions. If the lesions had highly suspicious 
characteristics of pathological stage 0 or I  lung 
cancer on CT or FDG-PET, are there any advan-
tages of preoperative pathological confirmation 
over the surgical and postoperative outcomes?
In the present study, preoperative patholo-
gical confirmation had no effect on the surgical 
or postoperative outcomes. According to those 
results, in the PPLs of highly suspected lung 
cancer with pathological stage 0 or I, surgical 
resection without PPD seems to be one of the 
feasible therapeutic strategies to avoid unneces-
sary complications of examination and delay to 
surgery. 
A core needle biopsy or wedge lung resection 
is commonly performed as surgical biopsy. Since 
the advent of VATS, the patient with undiagnosed 
PPL could have undertaken minimally invasive 
surgical biopsy using VATS approach compared 
to conventional open thoracotomy. In most of the 
cases with surgical biopsy using VATS approach, 
extending operation, including curative resection 
is decided after confirmation of frozen section 
results. In other words, the operation including 
curative resection of undiagnosed lesion requires 
waiting time for intraoperative frozen section 
analysis. Therefore, there were concerns over 
the prolonged operation time. In the present 
study, no significant differences in operation 
time were found between the PPD and non-PPD 
groups. With regard to surgical and postoperative 
outcomes, no significant differences were found 
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between the PPD and non-PPD groups. In the 
clinical setting, peeling off the area of pleural 
adhesions and preliminary dissection of the hilar 
structures, including lymph node to get ready 
for lobectomy can be started while waiting for 
the frozen section analysis, reducing waste of 
time. Moreover, previous studies have evaluated 
the risk factors associated with prolonged opera-
tion and postoperative complications, including 
pleural adhesion and incomplete fissure [18–20]. 
On the basis of our results and previous reports, 
we presume the absence of preoperative patho-
logical diagnosis does not affect the surgical and 
postoperative outcomes of VATS of pathological 
stage 0 or I lung cancer except for decreasing the 
rate of unnecessary resection. 
Today sublobar resection has been allowed 
for appropriate patients with the size of lesion 
≤ 20 mm, GGN with its consolidation tumor ratio 
≤ 50%, GGN with adenocarcinoma-in-situ, and 
lesion demonstrating a radiologic doubling time 
of ≥ 400 days, and they often exhibit pathologi-
cal stage 0 or I non-small cell lung cancer [21]. 
However, most physicians encounter clinical 
difficulties identifying those lesions by non-sur-
gical diagnosis due to their small size, absence of 
bronchus which reaches into the lesion, or their 
minimal changes in histology. In those lesions, if 
lung cancer is highly suspected, sublobar resec-
tion using VATS approach can safely provide both 
pathological diagnosis and curative treatment 
with minimal invasiveness, saving costs and 
avoiding complications of non-surgical biopsy. 
If suspicion of malignancy is not so strong, 
the probability of unnecessary resection of undia-
gnosed PPLs can be decreased by analysis of ra-
diologic characteristics and careful CT follow-up 
examination [22, 23]. Additionally, in the real 
world, sublobar resection has also been allowed 
in non-small cell lung cancer cases with no lymph 
node metastasis considered unsuitable for lobec-
tomy taking into account patient conditions (e.g., 
advanced age, coexisting comorbidities of chronic 
heart failure, and limited pulmonary function 
due to chronic obstructive pulmonary disease or 
interstitial lung disease). Considering the patient 
delicate conditions and risk of complications 
associated with non-surgical biopsy, there has 
been pros and cons whether non-surgical biopsy 
should be performed in cases with lesions highly 
suggesting early-stage non-small cell lung cancer. 
The present study has several limitations. 
First, it was retrospective, nonrandomized, and 
conducted at a single medical center. Second, the 
study did not evaluate how often preoperative 
examination decrease the benign resection rates 
of undiagnosed PPLs, which are one of the main 
purpose of bronchoscopy and CT-guided biopsy. 
Additionally, obtaining PPD is ideal in the lesions 
which have suspicion of primary lung cancer as 
well as metastases derived from other organs, 
which may influence selection of surgery treat-
ment. Third, the main preoperative diagnostic 
modality was bronchoscopy, which is reflective of 
the mode of operation in our institution. This may 
not be generalizable to other hospitals that mainly 
perform CT-guided biopsy for PPD. Prospective, 
randomized multicenter studies are needed for 
more accurate analysis.
Conclusions
The results of the present study show that 
obtaining PPD had less impact on surgical and 
postoperative outcomes of pathological stage 0 or 
I lung cancer, which suggests that direct surgical 
resection without an attempt to perform non-sur-
gical biopsy would be acceptable with careful 
selection of cases.
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